These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34982494)

  • 1. Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice.
    Pramfalk C; Ahmed O; Pedrelli M; Minniti ME; Luquet S; Denis RG; Olin M; Härdfeldt J; Vedin LL; Steffensen KR; Rydén M; Hodson L; Eriksson M; Parini P
    J Intern Med; 2022 Aug; 292(2):296-307. PubMed ID: 34982494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice.
    Ahmed O; Pramfalk C; Pedrelli M; Olin M; Steffensen KR; Eriksson M; Parini P
    Dig Liver Dis; 2019 Jul; 51(7):1016-1022. PubMed ID: 30630736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization.
    Alger HM; Brown JM; Sawyer JK; Kelley KL; Shah R; Wilson MD; Willingham MC; Rudel LL
    J Biol Chem; 2010 May; 285(19):14267-74. PubMed ID: 20231283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.
    Lopez AM; Posey KS; Turley SD
    Biochem Biophys Res Commun; 2014 Nov; 454(1):162-6. PubMed ID: 25450374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2.
    Zhang J; Sawyer JK; Marshall SM; Kelley KL; Davis MA; Wilson MD; Brown JM; Rudel LL
    Circ Res; 2014 Oct; 115(10):826-33. PubMed ID: 25239141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic acyl-coenzyme a:cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia.
    Devlin AM; Singh R; Bottiglieri T; Innis SM; Green TJ
    J Nutr; 2010 Feb; 140(2):231-7. PubMed ID: 20018805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice.
    Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice.
    Lee RG; Shah R; Sawyer JK; Hamilton RL; Parks JS; Rudel LL
    J Lipid Res; 2005 Jun; 46(6):1205-12. PubMed ID: 15805543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.
    Ohshiro T; Ohtawa M; Nagamitsu T; Matsuda D; Yagyu H; Davis MA; Rudel LL; Ishibashi S; Tomoda H
    J Pharmacol Exp Ther; 2015 Nov; 355(2):299-307. PubMed ID: 26338984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function.
    Lopez AM; Jones RD; Repa JJ; Turley SD
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G454-G463. PubMed ID: 29878847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
    Marshall SM; Gromovsky AD; Kelley KL; Davis MA; Wilson MD; Lee RG; Crooke RM; Graham MJ; Rudel LL; Brown JM; Temel RE
    PLoS One; 2014; 9(6):e98953. PubMed ID: 24901470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of acyl-coenzyme A:cholesterol acyltransferase-1 in the control of hepatic very low density lipoprotein secretion and low density lipoprotein receptor expression in the mouse and hamster.
    Spady DK; Willard MN; Meidell RS
    J Biol Chem; 2000 Sep; 275(35):27005-12. PubMed ID: 10869364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
    Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.
    Bell TA; Brown JM; Graham MJ; Lemonidis KM; Crooke RM; Rudel LL
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1814-20. PubMed ID: 16675724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual action of neutral sphingomyelinase on rat hepatocytes: activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion.
    Liza M; Chico Y; Fresnedo O; Ochoa B
    Lipids; 2003 Jan; 38(1):53-63. PubMed ID: 12669820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.
    Lian J; Wei E; Wang SP; Quiroga AD; Li L; Di Pardo A; van der Veen J; Sipione S; Mitchell GA; Lehner R
    Hepatology; 2012 Dec; 56(6):2154-62. PubMed ID: 22707181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells.
    Liang JJ; Oelkers P; Guo C; Chu PC; Dixon JL; Ginsberg HN; Sturley SL
    J Biol Chem; 2004 Oct; 279(43):44938-44. PubMed ID: 15308631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss.
    Brown JM; Bell TA; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL
    J Biol Chem; 2008 Apr; 283(16):10522-34. PubMed ID: 18281279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.